{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:11:45Z","timestamp":1780373505984,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Stevens\u2013Johnson Syndrome and Toxic Epidermal Necrolysis (SJS\/TEN) are part of a disease continuum of vesiculobullous mucocutaneous reactions affecting the skin and mucous membranes including the ocular surface. Manifestations of disease range from mild dry eye to progressive conjunctival cicatrisation, limbal epithelial stem cell failure and corneal blindness. In Far Eastern and South East Asian populations where SJS\/TEN is prevalent, numerous human leukocyte antigen (HLA) gene variants at the A, B and C loci have been identified as risk factors for developing SJS\/TEN with severe ocular complications (SOC). By contrast, the incidence of SJS\/TEN with SOC in European countries is relatively low. To date, ocular SJS\/TEN risk altering alleles have not been widely investigated in European populations. In this study, we analysed the association of HLA -A, -B and -C alleles with SJS\/TEN in 33 patients residing in the UK with age matched controls. The data showed statistically significant novel negative allele association with HLA-B*0702 and a trend with HLA-C*0702 in the patient group, indicating these alleles are protective. Further characterisation of protective and risk alleles in other ethnic groups is required to fully elucidate the putative role of these alleles in the susceptibility of SJS\/TEN with or without severe ocular complications in patients in the UK.<\/jats:p>","DOI":"10.1038\/s41598-021-82400-3","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T11:10:36Z","timestamp":1612350636000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Human leukocyte antigen B*0702 is protective against ocular Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis in the UK population"],"prefix":"10.1038","volume":"11","author":[{"given":"Gibran F.","family":"Butt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham R.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjad","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Ueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saaeha","family":"Rauz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,3]]},"reference":[{"issue":"6","key":"82400_CR1","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/bjd.14530","volume":"174","author":"D Creamer","year":"2016","unstructured":"Creamer, D. et al. U.K. guidelines for the management of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis in adults 2016. Br. J. Dermatol. 174(6), 1194\u20131227. https:\/\/doi.org\/10.1111\/bjd.14530 (2016).","journal-title":"Br. J. Dermatol."},{"issue":"9","key":"82400_CR2","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/eye.2012.119","volume":"26","author":"CF Radford","year":"2012","unstructured":"Radford, C. F., Rauz, S., Williams, G. P., Saw, V. P. J. & Dart, J. K. G. Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United Kingdom. Eye 26(9), 1199\u20131208 (2012).","journal-title":"Eye"},{"issue":"6","key":"82400_CR3","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.jid.2017.01.031","volume":"137","author":"N Frey","year":"2017","unstructured":"Frey, N. et al. The epidemiology of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis\u00a0in the UK. J. Invest. Dermatol. 137(6), 1240\u20131247 (2017).","journal-title":"J. Invest. Dermatol."},{"issue":"12","key":"82400_CR4","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1111\/j.1528-1167.2010.02766.x","volume":"51","author":"N Kaniwa","year":"2010","unstructured":"Kaniwa, N. et al. HLA-B*1511 is a risk factor for carbamazepine-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Epilepsia 51(12), 2461\u20132465 (2010).","journal-title":"Epilepsia"},{"issue":"11","key":"82400_CR5","first-page":"165933","volume":"11","author":"MS Yang","year":"2016","unstructured":"Yang, M. S. et al. Incidence of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a nationwide population-based study using national health insurance database in Korea. PLoS ONE 11(11), 165933 (2016).","journal-title":"PLoS ONE"},{"key":"82400_CR6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s40257-015-0158-0","volume":"16","author":"RP Dodiuk-Gad","year":"2015","unstructured":"Dodiuk-Gad, R. P., Chung, W. H., Valeyrie-Allanore, L. & Shear, N. H. Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: an update. Am. J. Clin. Dermatol. 16, 475\u2013493 (2015).","journal-title":"Am. J. Clin. Dermatol."},{"issue":"7","key":"82400_CR7","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.jid.2016.03.023","volume":"136","author":"DY Hsu","year":"2016","unstructured":"Hsu, D. Y., Brieva, J., Silverberg, N. B. & Silverberg, J. I. Morbidity and mortality of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in United States adults. J. Invest. Dermatol. 136(7), 1387\u20131397 (2016).","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"82400_CR8","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1542\/peds.2006-2401","volume":"119","author":"KA Ravin","year":"2007","unstructured":"Ravin, K. A. et al. Mycoplasma pneumoniae and atypical Stevens-Johnson syndrome: a case series. Pediatrics 119(4), 1002\u20131005 (2007).","journal-title":"Pediatrics"},{"issue":"7","key":"82400_CR9","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1001\/archinte.1992.00400190131024","volume":"152","author":"PF Detjen","year":"1992","unstructured":"Detjen, P. F., Patterson, R., Noskin, G. A., Phair, J. P. & Loyd, S. O. Herpes simplex virus associated with recurrent Stevens\u2013Johnson syndrome: a management strategy. Arch. Intern. Med. 152(7), 1513\u20131516 (1992).","journal-title":"Arch. Intern. Med."},{"issue":"12","key":"82400_CR10","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/nm.1884","volume":"14","author":"WH Chung","year":"2008","unstructured":"Chung, W. H. et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Nat. Med. 14(12), 1343\u20131350 (2008).","journal-title":"Nat. Med."},{"key":"82400_CR11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1126\/science.282.5388.490","volume":"282","author":"I Viard","year":"1998","unstructured":"Viard, I. et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282, 490\u2013493 (1998).","journal-title":"Science"},{"issue":"SUPPL. 3","key":"82400_CR12","first-page":"31","volume":"4","author":"R Nakamura","year":"2014","unstructured":"Nakamura, R. et al. HLA association with antipyretic analgesics-induced Stevens\u2013Johnson Syndrome\/toxic epidermal necrolysis with severe ocular surface complications in Japanese patients. Clin. Transl. Allergy 4(SUPPL. 3), 31 (2014).","journal-title":"Clin. Transl. Allergy"},{"issue":"2","key":"82400_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/ICO.0000000000000708","volume":"5","author":"HS Lee","year":"2016","unstructured":"Lee, H. S. et al. Analysis of ocular manifestation and genetic association of allopurinol-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in South Korea. Cornea 5(2), 199\u2013204 (2016).","journal-title":"Cornea"},{"issue":"9","key":"82400_CR14","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/S0161-6420(96)30491-0","volume":"103","author":"WJ Power","year":"1996","unstructured":"Power, W. J. et al. HLA typing in patients with ocular manifestations of Stevens\u2013Johnson syndrome. Ophthalmology 103(9), 1406\u20131409 (1996).","journal-title":"Ophthalmology"},{"issue":"9","key":"82400_CR15","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1136\/bjophthalmol-2017-311823","volume":"102","author":"P Jongkhajornpong","year":"2018","unstructured":"Jongkhajornpong, P. et al. Association between HLA-B*44:03-HLA-C*07:01 haplotype and cold medicine-related Stevens-Johnson syndrome with severe ocular complications in Thailand. Br. J. Ophthalmol. 102(9), 1303\u20131307 (2018).","journal-title":"Br. J. Ophthalmol."},{"issue":"2","key":"82400_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1515\/dmdi-2013-0046","volume":"29","author":"NM Jaramillo","year":"2014","unstructured":"Jaramillo, N. M. et al. Pharmacogenetic potential biomarkers for carbamazepine adverse drug reactions and clinical response. Drug Metabol. Drug Interact. 29(2), 67\u201379 (2014).","journal-title":"Drug Metabol. Drug Interact."},{"issue":"12","key":"82400_CR17","first-page":"3880","volume":"57","author":"TH Wakamatsu","year":"2016","unstructured":"Wakamatsu, T. H. et al. HLA class I genes associated with cold medicine related Stevens-Johnson syndrome with severe ocular complications in the Brazilian population. Investig. Ophthalmol. Vis. Sci. 57(12), 3880 (2016).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"82400_CR18","doi-asserted-by":"crossref","unstructured":"Ueta, M. et al. Significant association between HLA-B*44:03 and cold medicine related Stevens\u2013Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) with severe ocular complications in various ethnic populations. Clin. Transl. Allergy. 8(3) (2018).","DOI":"10.3389\/fmed.2021.651247"},{"issue":"1","key":"82400_CR19","doi-asserted-by":"publisher","first-page":"16240","DOI":"10.1038\/s41598-019-52619-2","volume":"9","author":"K Nakatani","year":"2019","unstructured":"Nakatani, K. et al. Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing. Sci. Rep. 9(1), 16240 (2019).","journal-title":"Sci. Rep."},{"issue":"3","key":"82400_CR20","first-page":"7","volume":"4","author":"M Ueta","year":"2014","unstructured":"Ueta, M., Sotozono, C., Sawai, H., Tokunaga, K. & Kinoshita, S. Strong association between hla-a*02:06 and acetaminophen-related Stevens\u2013Johnson syndrome with severe mucosal involvements in the Japanese. Clin. Transl. Allergy 4(3), 7\u20138 (2014).","journal-title":"Clin. Transl. Allergy"},{"issue":"13","key":"82400_CR21","first-page":"4064","volume":"55","author":"M Ueta","year":"2014","unstructured":"Ueta, M. & Sotozono, C. HLA markers of cold medicine-related Stevens-Johnson syndrome with severe mucosal involvements in the Japanese. Investig. Ophthalmol. Vis. Sci. 55(13), 4064 (2014).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"4","key":"82400_CR22","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1136\/bjophthalmol-2018-313263","volume":"103","author":"I Jun","year":"2019","unstructured":"Jun, I. et al. Association of human antigen class i genes with cold medicine-related Stevens-Johnson syndrome with severe ocular complications in a Korean population. Br. J. Ophthalmol. 103(4), 573\u2013576 (2019).","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"82400_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41439-019-0082-6","volume":"6","author":"M Ueta","year":"2019","unstructured":"Ueta, M. et al. Association of HLA class I and II gene polymorphisms with acetaminophen-related Stevens\u2013Johnson syndrome with severe ocular complications in Japanese individuals. Hum. Genome Var. 6(1), 1\u20136 (2019).","journal-title":"Hum. Genome Var."},{"issue":"4","key":"82400_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1001\/jamaophthalmol.2017.0074","volume":"135","author":"TH Wakamatsu","year":"2017","unstructured":"Wakamatsu, T. H. et al. Human leukocyte antigen class I genes associated with Stevens-Johnson syndrome and severe ocular complications following use of cold medicine in a Brazilian population. JAMA Ophthalmol. 135(4), 355\u2013360 (2017).","journal-title":"JAMA Ophthalmol."},{"key":"82400_CR25","doi-asserted-by":"crossref","unstructured":"Kannabiran, C. et al. Association of human leukocyte antigen class 1 genes with Stevens Johnson Syndrome with severe ocular complications in an Indian population. Sci. Rep. 7(1) (2017).","DOI":"10.1038\/s41598-017-15965-7"},{"key":"82400_CR26","first-page":"550","volume":"14","author":"M Ueta","year":"2008","unstructured":"Ueta, M. et al. HLA class I and II gene polymorphisms in Stevens\u2013Johnson syndrome with ocular complications in Japanese. Mol. Vis. 14, 550\u2013555 (2008).","journal-title":"Mol. Vis."},{"key":"82400_CR27","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1038\/srep04862","volume":"4","author":"M Ueta","year":"2014","unstructured":"Ueta, M. et al. Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens\u2013Johnson syndrome with severe mucosal involvement. Sci. Rep. 4, 4862 (2014).","journal-title":"Sci. Rep."},{"key":"82400_CR28","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.1038\/srep05981","volume":"4","author":"M Ueta","year":"2014","unstructured":"Ueta, M. et al. Trans-ethnic study confirmed independent associations of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens\u2013Johnson syndrome with severe ocular surface complications. Sci. Rep. 4, 5981 (2014).","journal-title":"Sci. Rep."},{"issue":"2","key":"82400_CR29","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ajo.2006.09.029","volume":"143","author":"M Ueta","year":"2007","unstructured":"Ueta, M., Sotozono, C., Tokunaga, K., Yabe, T. & Kinoshita, S. Strong association between HLA-A*0206 and Stevens\u2013Johnson syndrome in the Japanese. Am. J. Ophthalmol. 143(2), 367\u2013368 (2007).","journal-title":"Am. J. Ophthalmol."},{"issue":"2","key":"82400_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1001\/archdermatol.2009.540","volume":"145","author":"J Gueudry","year":"2009","unstructured":"Gueudry, J., Roujeau, J. C., Binaghi, M., Soubrane, G. & Muraine, M. Risk factors for the development of ocular complications of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Arch. Dermatol. 145(2), 157\u2013162 (2009).","journal-title":"Arch. Dermatol."},{"key":"82400_CR31","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1398-9995.2006.01295.x","volume":"62","author":"LW Yip","year":"2007","unstructured":"Yip, L. W. et al. Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series. Allergy Eur. J. Allergy Clin. Immunol. 62, 527\u2013531 (2007).","journal-title":"Allergy Eur. J. Allergy Clin. Immunol."},{"issue":"8","key":"82400_CR32","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1136\/bjo.2006.109124","volume":"91","author":"M Victoria De Rojas","year":"2007","unstructured":"Victoria De Rojas, M., Dart, J. K. G. & Saw, V. P. J. The natural history of Stevens\u2013Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. Br. J. Ophthalmol. 91(8), 1048\u20131053 (2007).","journal-title":"Br. J. Ophthalmol."},{"issue":"7","key":"82400_CR33","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.ophtha.2006.10.029","volume":"114","author":"C Sotozono","year":"2007","unstructured":"Sotozono, C. et al. New grading system for the evaluation of chronic ocular manifestations in patients with Stevens\u2013Johnson syndrome. Ophthalmology 114(7), 1294\u20131302 (2007).","journal-title":"Ophthalmology"},{"issue":"4","key":"82400_CR34","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ophtha.2008.12.048","volume":"116","author":"C Sotozono","year":"2009","unstructured":"Sotozono, C. et al. Diagnosis and treatment of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis with ocular complications. Ophthalmology 116(4), 685\u2013690 (2009).","journal-title":"Ophthalmology"},{"issue":"2","key":"82400_CR35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ajo.2015.05.002","volume":"160","author":"C Sotozono","year":"2015","unstructured":"Sotozono, C. et al. Predictive factors associated with acute ocular involvement in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Am. J. Ophthalmol. 160(2), 228-237.e2 (2015).","journal-title":"Am. J. Ophthalmol."},{"issue":"14 Special Issu","key":"82400_CR36","doi-asserted-by":"publisher","first-page":"DES183","DOI":"10.1167\/iovs.17-23537","volume":"59","author":"M Ueta","year":"2018","unstructured":"Ueta, M. Results of detailed investigations into Stevens\u2013Johnson syndrome with severe ocular complications. Investig. Ophthalmol. Vis. Sci. 59(14 Special Issue), DES183\u2013DES191 (2018).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"4","key":"82400_CR37","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1001\/jamaophthalmol.2017.0074","volume":"135","author":"TH Wakamatsu","year":"2017","unstructured":"Wakamatsu, T. H. et al. Human leukocyte antigen class i genes associated with Stevens\u2013Johnson syndrome and severe ocular complications following use of cold medicine in a Brazilian population. JAMA Ophthalmol. 135(4), 355\u2013360 (2017).","journal-title":"JAMA Ophthalmol."},{"issue":"5","key":"82400_CR38","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1167\/iovs.07-1401","volume":"49","author":"M Ueta","year":"2008","unstructured":"Ueta, M. et al. Association of combined IL-13\/IL-4R signaling pathway gene polymorphism with stevens-johnson syndrome accompanied by ocular surface complications. Investig. Ophthalmol. Vis. Sci. 49(5), 1809\u20131813 (2008).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"2","key":"82400_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1515\/dmdi-2013-0046","volume":"29","author":"NM Jaramillo","year":"2014","unstructured":"Jaramillo, N. M., Galindo, I. F., Vazquez, A. O., Cook, H. J. & LLerena A, Lopez ML, ,. Pharmacogenetic potential biomarkers for carbamazepine adverse drug reactions and clinical response. Drug Metabol Drug Interact. 29(2), 67\u201379 (2014).","journal-title":"Drug Metabol Drug Interact."},{"key":"82400_CR40","unstructured":"Gonzalez-Galarza, F. et al. Allele*Frequency.net. http:\/\/www.allelefrequencies.net\/default.asp"},{"issue":"10","key":"82400_CR41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/epi.13087","volume":"56","author":"J Moon","year":"2015","unstructured":"Moon, J. et al. The HLA-A*2402\/Cw*0102 haplotype is associated with lamotrigine-induced maculopapular eruption in the Korean population. Epilepsia 56(10), 161\u2013167. https:\/\/doi.org\/10.1111\/epi.13087 (2015).","journal-title":"Epilepsia"},{"issue":"2","key":"82400_CR42","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1528-1167.2009.02269.x","volume":"51","author":"H Ikeda","year":"2010","unstructured":"Ikeda, H. et al. HLA Class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions. Epilepsia 51(2), 297\u2013300. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02269.x (2010).","journal-title":"Epilepsia"},{"issue":"6","key":"82400_CR43","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2217\/14622416.7.6.813","volume":"7","author":"A Alfirevic","year":"2006","unstructured":"Alfirevic, A. et al. HLA-B locus in Caucasian patients with carbamazepine hypersensitivity. Pharmacogenomics 7(6), 813\u2013818 (2006).","journal-title":"Pharmacogenomics"},{"issue":"11","key":"82400_CR44","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.2217\/pgs.12.108","volume":"13","author":"R Pavlos","year":"2012","unstructured":"Pavlos, R., Mallal, S., Phillips, E., Pavlos, R. & Mallal, S. HLA and pharmacogenetics of drug hypersensitivity. Pharmacogenomics 13(11), 1285\u20131306 (2012).","journal-title":"Pharmacogenomics"},{"issue":"DEC","key":"82400_CR45","first-page":"11","volume":"8","author":"L Hosie","year":"2017","unstructured":"Hosie, L. et al. Cytomegalovirus-specific T cells restricted by HLA-Cw*0702 increase markedly with age and dominate the CD8+ T-cell repertoire in older people. Front. Immunol. 8(DEC), 11 (2017).","journal-title":"Front. Immunol."},{"issue":"22","key":"82400_CR46","doi-asserted-by":"publisher","first-page":"E2046","DOI":"10.1073\/pnas.1305227110","volume":"110","author":"D Weiskopf","year":"2013","unstructured":"Weiskopf, D. et al. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells. Proc. Natl. Acad. Sci. U. S. A. 110(22), E2046\u2013E2053 (2013).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82400-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82400-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82400-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:54:59Z","timestamp":1670036099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82400-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,3]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["82400"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-82400-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,3]]},"assertion":[{"value":"25 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2928"}}